The U.S. Food and Drug Administration announced Thursday it halted all new clinical trials that entail sending Americans’ genetic data to international labs.
Based on “mounting evidence,” the FDA said, some U.S. companies did not inform trial participants that their living cells were sent to foreign labs, including in China, for genetic engineering before reinfusion into patients.
Read the full story
One in ten patients experience a “serious adverse event” after taking the abortion pill, according to a study released Monday by the Ethics and Public Policy Center (EPPC), a conservative think tank and advocacy group.
The study found that 10.93% of women experienced sepsis, infection, hemorrhaging, or another serious adverse event within 45 days after a mifepristone abortion. The real-world rate of serious adverse events after mifepristone abortions is at least 22 times as high as the summary figure of “less than 0.5%” in clinical trials reported on the drug label, according to the study.
Read the full story
The Senate confirmed two of President Donald Trump’s health nominees Tuesday evening, largely along party lines, in a win for the ‘Make America Healthy Again’ movement.
Read the full story